Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 250568, 7 pages
http://dx.doi.org/10.1155/2008/250568
Review Article

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor

1Department of Human Morphology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
2Department of Orthopaedic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan

Received 1 March 2008; Accepted 17 July 2008

Academic Editor: Dipak Panigrahy

Copyright © 2008 K. Nishida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • J. C. M. Clark, C. R. Dass, and P. F. M. Choong, “Development of chondrosarcoma animal models for assessment of adjuvant therapy,” Anz Journal Of Surgery, vol. 79, no. 5, pp. 327–336, 2009. View at PublisherView at Google Scholar
  • Nuor Jamil, Sarah Howie, and Donald M. Salter, “Therapeutic molecular targets in human chondrosarcoma,” International Journal of Experimental Pathology, vol. 91, no. 5, pp. 387–393, 2010. View at PublisherView at Google Scholar
  • Eric R. Wagner, Bai-Cheng He, Liang Chen, Guo-Wei Zuo, Wenli Zhang, Qiong Shi, Qing Luo, Xiaoji Luo, Bo Liu, Jinyong Luo, Farbod Rastegar, Connie J. He, Yawen Hu, Barrett Boody, Hue H. Luu, Tong-Chuan He, Zhong-Liang Deng, and Rex C. Haydon, “Therapeutic Implications of PPARγ in Human Osteosarcoma,” PPAR Research, vol. 2010, pp. 1–16, 2010. View at PublisherView at Google Scholar
  • Orin Bloch, Michael E. Sughrue, Steven A. Mills, and Andrew T. Parsa, “Signaling pathways in cranial chondrosarcoma: potential molecular targets for directed chemotherapy,” Journal of Clinical Neuroscience, vol. 18, no. 7, pp. 881–885, 2011. View at PublisherView at Google Scholar
  • Joseph G. Sinkovics, “Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review),” International Journal Of Oncology, vol. 40, no. 2, pp. 305–349, 2012. View at PublisherView at Google Scholar
  • Vivek Subbiah, Robert E. Brown, Jamie Buryanek, Jonathan Trent, Avi Ashkenazi, Roy Herbst, and Razelle Kurzrock, “Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist,” Molecular Cancer Therapeutics, vol. 11, no. 11, pp. 2541–2546, 2012. View at PublisherView at Google Scholar
  • Pu Wang, Pei-Pei Guan, Chuang Guo, Fei Zhu, Konstantinos Konstantopoulos, and Zhan-You Wang, “Fluid shear stress-induced osteoarthritis: roles of cyclooxygenase-2 and its metabolic products in inducing the expression of proinflammatory cytokines and matrix metalloproteinases,” Faseb Journal, vol. 27, no. 12, pp. 4664–4677, 2013. View at PublisherView at Google Scholar
  • A. Italiano, O. Mir, A. Cioffi, E. Palmerini, S. Piperno-Neumann, C. Perrin, L. Chaigneau, N. Penel, F. Duffaud, J. E. Kurtz, O. Collard, F. Bertucci, E. Bompas, A. Le Cesne, R. G. Maki, I. Ray Coquard, and J. Y. Blay, “Advanced chondrosarcomas: role of chemotherapy and survival,” Annals of Oncology, 2013. View at PublisherView at Google Scholar
  • Ozlem Cakmak, Ismail Comertoglu, Ridvan Firat, Haci Kemal Erdemli, S. Fatih Kursunlu, Sumeyya Akyol, Veli Ugurcu, Aynur Altuntas, Bahattin Adam, and Kadir Demircan, “The Investigation of ADAMTS16 in Insulin-Induced Human Chondrosarcoma Cells,” Cancer Biotherapy and Radiopharmaceuticals, vol. 30, no. 6, pp. 255–260, 2015. View at PublisherView at Google Scholar
  • Sumeyya Akyol, İsmail C�mertoğlu, Ridvan Firat, �zlem �akmak, Yunus Yukselten, G�n�l Erden, Veli Ugurcu, and Kadir Demircan, “Effect of insulin on the mRNA expression of procollagen N-proteinases in chondrosarcoma OUMS-27 cells,” Oncology Letters, 2015. View at PublisherView at Google Scholar
  • Bunyamin Isik, Haci K. Erdemli, Ismail Comertoglu, Sumeyya Akyol, Ridvan Firat, Mehmet Kaya, Omer Akyol, and Kadir Demircan, “Changes of the Expressions of Orphan and gon-ADAMTS in Chondrosarcoma Cells,” Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol. 25, no. 3, pp. 158–165, 2015. View at PublisherView at Google Scholar
  • Takashi Higuchi, Akihiko Takeuchi, Seiichi Munesue, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Hiroyuki Inatani, Shingo Shimozaki, Takashi Kato, Yu Aoki, Kensaku Abe, Yuta Taniguchi, Hisaki Aiba, Hideki Murakami, Ai Harashima, Yasuhiko Yamamoto, and Hiroyuki Tsuchiya, “Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression,” Cancer Medicine, 2018. View at PublisherView at Google Scholar